BIO Announces Initial Companies Selected to Present at the Twelfth Annual BIO® CEO & Investor Conference
Over 120 presenting companies will be selected and posted on the conference website on a rolling basis. To view the latest list, please visit http://ceo.bio.org.
This year’s presenting companies were chosen using metrics developed by BIO’s internal Industry Analysis team and were further vetted by an Advisory Committee, comprised of members from top-tier investment firms and CEOs from leading biotech companies:
· Alger Boyer; Managing Director, Equities Group, Rodman & Renshaw, LLC
· Benjamin R. Bowen, Ph.D.; Managing Director, Investment Banking , Rodman & Renshaw, LLC
· Ron Cohen, M.D.; President & CEO, Acorda Therapeutics
· J. Donald deBethizy, Ph.D.; President & CEO, Targacept
· David Farhadi, M.D.; Vice President, Senior Analyst/Co-Portfolio Manager, Fred Alger Management, Inc.
· Howard Furst, M.D.; Partner, Deerfield Management
· Cory W. Kasimov; Vice President , J.P Morgan
· David Kroin; Managing Director, Great Point Partners, LLC
· Kelly Lisbakken; Vice President, Investment Banking, Wedbush PacGrow Life Sciences
· Mark Schoenebaum, M.D.; Managing Director & Senior Biotechnology Analyst, Deutsche Bank AG
· Chris Swindle; Managing Director, Wedbush PacGrow Life Sciences
“The BIO CEO & Investor Conference will showcase companies representing the industry’s most promising investment opportunities with late-stage clinical pipelines, well-established business strategies or strong M&A and partnering potential,” said Alan Eisenberg, executive vice president, Emerging Companies & Business Development at BIO. “Selected companies are also distinguished by significant opportunities for value creation with near-term clinical, regulatory and corporate catalysts that will continue to foster the growth of our industry in the new decade.”
Now in its twelfth year, the BIO CEO & Investor Conference is the largest independent investor conference for the life sciences industry focused on publicly-traded biotechnology companies. The meeting provides a neutral forum where institutional investors, industry analysts, and senior executives from leading global pharmaceutical and biotechnology companies have the opportunity to shape the future investment landscape of the biotechnology industry.
This year’s meeting will feature issue-oriented plenary sessions, company presentations and educational sessions focused on business trends and hot therapeutic areas in life sciences. Access to top investors and industry executives will also be powered by BIO One-on-One Partnering, BIO’s interactive online system that allows you to intelligently search, contact and schedule one-on-one meetings.
To learn more about the BIO CEO & Investor Conference, including registration and program information, please visit http://ceo.bio.org/. Registration is complimentary for qualified investors and credentialed members of the media.
The following companies will present at the Twelfth Annual BIO CEO & Investor Conference:
4SC AG (VSC)
Acorda Therapeutics Inc. (ACOR)
Actelion Ltd. (ATLN)
Acucela Inc. (Private)
Addex Pharmaceuticals S.A. (ADXN)
Affymax Inc. (AFFY)
Alexza Pharmaceuticals Inc. (ALXA)
Alkermes Inc. (ALKS)
Allon Therapeutics Inc. (NPCUF)
Allos Therapeutics Inc. (ALTH)
Alnylam Pharmaceuticals Inc. (ALNY)
Amarin Corp. PLC (AMRN)
Amsterdam Molecular Therapeutics Holding N.V. (AMT)
Anadys Pharmaceuticals Inc. (ANDS)
ARCA biopharma, Inc. (ABIO)
Ardea Biosciences Inc. (RDEA)
Arena Pharmaceuticals Inc. (ARNA)
Array BioPharma Inc. (ARRY)
Bavarian Nordic A/S (BAVA)
BioCryst Pharmaceuticals Inc. (BCRX)
BioMarin Pharmaceutical Inc. (BMRN)
Bionomics Ltd. (BNO)
BioSante Pharmaceuticals Inc. (BPAX)
BioTie Therapies Oyj (BTH1V)
Cell Therapeutics Inc. (CTIC)
Cellectis S.A. (ALCLS)
CEL-SCI Corp. (CVM)
CERUS CORP (CERS)
Chelsea Therapeutics International Ltd. (CHTP)
ChemGenex Pharmaceuticals Ltd. (CXS)
Cleveland BioLabs Inc. (CBLI)
CombinatoRx Inc. (CRXX)
Curis Inc. (CRIS)
Cyclacel Pharmaceuticals Inc. (CYCC)
Cytokinetics Inc. (CYTK)
DepoMed Inc. (DEPO)
Diamyd Medical AB (DMYDF)
Discovery Laboratories Inc. (DSCO)
DUSA (DUSA)
Dyax Corp. (DYAX)
Elan Pharmaceuticals (Private)
EMISPHERE TECHNOLOGIES INC (EMIS)
EpiCept Corporation (EPCT)
Exelixis Inc. (EXEL)
Genta Inc. (GETA)
GenVec Inc. (GNVC)
GeoVax Labs Inc. (GOVX)
Geron Corp. (GERN)
Gilead Sciences Inc. (GILD)
GlobeImmune (Private)
Hana Biosciences, Inc (HNAB)
Human Genome Sciences Inc. (HGSI)
Icagen, Inc. (ICGN)
Idenix Pharmaceuticals Inc. (IDIX)
Idera Pharmaceuticals Inc. (IDRA)
Immunogen Inc. (IMGN)
Immunovaccine Inc. (IMV)
Inovio Biomedical Corp. (INO)
Ista Pharmaceuticals Inc. (ISTA)
Javelin Pharmaceuticals, Inc. (JAV)
Lexicon Pharmaceuticals Inc. (LXRX)
Ligand Pharmaceuticals Inc. (LGND)
MannKind Corp. (MNKD)
MDRNA Inc. (MRNA)
Medivation Inc. (MDVN)
Micromet Inc. (MITI)
Molecular Insight Pharmaceuticals Inc. (MIPI)
MolMed S.p.A. (MLM)
Momenta Pharmaceuticals Inc. (MNTA)
Neuralstem Inc. (CUR)
NeurogesX Inc. (NGSX)
NexMed Inc. (NEXM)
NicOx S.A. (COX)
Nile Therapeutics Inc. (NLTX)
NovaBay Pharmaceuticals Inc. (NBY)
Novavax Inc. (NVX)
NPS Pharmaceuticals Inc. (NPSP)
Oncolytics Biotech Inc. (ONC)
Oncothyreon Inc. (ONTY)
Orexigen Therapeutics Inc. (OREX)
Paion AG (PA8)
PDL BioPharma Inc. (PDLI)
Pharmacyclics Inc. (PCYC)
Poniard Pharmaceuticals Inc. (PARD)
Prolor Biotech Inc. (PBTH)
Repligen Corp. (RGEN)
Resverlogix Corp. (RVX)
Rexahn Pharmaceuticals Inc. (RNN)
Rigel Pharmaceuticals Inc. (RIGL)
RXI Pharmaceuticals Corp. (RXII)
Sangamo BioSciences Inc. (SGMO)
Soligenix, Inc. (SNGX)
Somaxon Pharmaceuticals Inc. (SOMX)
Spectrum Pharmaceuticals Inc. (SPPI)
SuperGen Inc. (SUPG)
SYGNIS Pharma AG (LIO)
Targacept Inc. (TRGT)
Transgenomic Inc. (TBIO)
Vertex Pharmaceuticals Inc. (VRTX)
VirtualScopics Inc. (VSCP)
VIVUS Inc. (VVUS)
XOMA Ltd. (XOMA)
YM BioSciences Inc. (YM)
BIO CEO & Investor Conference Bank Sponsors
BIO is pleased to acknowledge the leadership provided by the BIO CEO & Investor Conference bank sponsors, including Lead Bank Sponsor Wedbush PacGrow Life Sciences, Conference Co-Host Rodman & Renshaw, LLC and Supporting Bank Sponsor Lazard.
Upcoming BIO Events
7th Annual BIO Asia Partnering Conference
January 25-26, 2010
Tokyo, Japan
12th Annual BIO CEO & Investor Conference
February 8-9, 2010
New York, NY
9th Annual Windhover & Windhover PSO
February 23-25, 2010
New York City, NY
BIO-Europe Spring
March 8-10, 2010
Barcelona, Spain
BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA
Partnering for Global Health
May 3, 2010
Chicago, IL
McCormick Place Convention Center
BIO International Convention
May 3-6, 2010
Chicago, IL
McCormick Place Convention Center
2010 BIO Human Resources Conference
May 4-7, 2010
Chicago, IL
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
###